JAKARTA - In FY2019, PT Darya Varia Laboratoria Tbk (DVLA) recorded a 10.54% net profit growth from its record in 2018 (Rp 200.65 billion) to Rp 221.78 billion.
According to the company's financial statements, the company managed to record 5.8% revenue growth in 2019 to Rp 1.8 trillion.
The segment that experienced the most growth was over the counter drug segment (7.25% YoY to Rp 705.04 billion), followed by exports (6.65% YoY to Rp 442.1 billion), and prescription drug (5.98% YoY to Rp 614.79 billion). (ARM/AR)